Cargando…
Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma
BACKGROUND: There is a paucity of information about the molecular perturbations involved in MPM tumor formation. We previously reported that EGFR-TK mutations in MPM were predictive of achieving optimal surgical cytoreduction, but the status of EGFR pathway activation potential of these mutations wa...
Autores principales: | Foster, Jason M, Radhakrishna, Uppala, Govindarajan, Venkatesh, Carreau, Joseph H, Gatalica, Zoran, Sharma, Poonam, Nath, Swapan K, Loggie, Brian W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970593/ https://www.ncbi.nlm.nih.gov/pubmed/20942962 http://dx.doi.org/10.1186/1477-7819-8-88 |
Ejemplares similares
-
Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies
por: Kuracha, Murali R., et al.
Publicado: (2017) -
Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022) -
Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis
por: Foster, Jason M., et al.
Publicado: (2016) -
Peritoneal Malignant Psammomatous Mesothelioma
por: Pusiol, Teresa, et al.
Publicado: (2010) -
Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma
por: Liang, Yufei, et al.
Publicado: (2019)